logo
  • 热门搜索词:
热门搜索词:专利数据招投标二手房交易数据专利引用数据世界版上市公司专利上市公司招聘股吧文本数据工商统计数据法拍房新闻报纸数据
新冠疫情数据

中国核酸检测机构及采样点数据NEW

中国核酸检测机构信息表
中国核酸采样点信息表

核酸检测机构工商注册数据NEW

核酸检测机构工商基础数据
核酸检测机构注册出资数据
核酸检测机构实际控制人数据
核酸检测机构股东基础数据
核酸检测机构股东对外投资数据
核酸检测机构对外投资数据
核酸检测机构控制企业数据
核酸检测机构工商变更数据

全国小区新冠病毒确诊病例数数据

新冠病毒防疫专利信息数据OPEN

中国防疫专利信息表
世界防疫专利信息表
中国防疫专利法律状态表

新冠病毒防疫企业捐赠数据OPEN

新冠病毒防疫标准信息数据OPEN

医用防护产品全表
口岸卫生检疫表
医用基础设施全表

    Introduction to COVID-19 Epidemic Prevention Patent Information Data

  The 2019 novel coronavirus (2019-nCoV), discovered through cases of viral pneumonia in Wuhan in 2019, was officially named by the World Health Organization on January 12, 2020. Coronaviruses constitute a large family of viruses known to cause illnesses ranging from common colds to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The novel coronavirus represents a new strain previously unidentified in humans.

  On January 21, 2020, the National Health Commission issued Announcement No. 1, classifying pneumonia caused by the novel coronavirus as a Category B infectious disease under the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, while implementing preventive and control measures for Category A infectious diseases. Over eighteen months since its initial large-scale outbreak, the Chinese government has accumulated substantial experience in epidemic containment. However, the pandemic persists, with continuous efforts across China and globally to combat the virus. During the early stages, China rapidly isolated the virus, completed whole-genome sequencing, developed nucleic acid detection kits, and received WHO recognition for its sequencing speed. Although no specific treatment exists for COVID-19, many symptoms can be managed through clinical care, while vaccine and therapeutic development remains urgently prioritized.

  The CnOpenData platform aggregates patent information related to COVID-19 prevention, providing foundational support for scientific research and clinical treatment. The dataset encompasses multiple domains: therapeutic drugs, prophylactic medications, detection and diagnostic kits, medical devices, protective equipment, medical disinfection, medical waste treatment, and wastewater management, aiming to facilitate coronavirus analysis, scientific epidemic control, and drug development.

  The CnOpenData team supports medical research and public health initiatives by opening access to COVID-19 prevention patent information data (contact customer service for access), with the hope of accelerating pandemic containment efforts.


Temporal Coverage

By filing date:

  • Chinese Epidemic Prevention Patent Information: July 1992 - December 2019
  • Global Epidemic Prevention Patent Information: April 1912 - August 2019

By publication date:

  • Chinese Epidemic Prevention Patent Information: April 1993 - January 2020
  • Global Epidemic Prevention Patent Information: June 1913 - October 2019

Data Structure Visualization

COVID-19 Prevention Patent Data Structure Diagram


Field Specifications


Sample Data

Chinese Epidemic Prevention Patent Information

Chinese Patent Legal Status Information

Global Epidemic Prevention Patent Information


Data Update Frequency

Annual updates